Akers BioSciences, Inc. Announces Pricing of Approximately $8 Million Public Offering
05 déc. 2019 09h25 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the...